Clinical Trials Logo

Clinical Trial Summary

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.


Clinical Trial Description

This is an exploratory study involving blood coagulation assays in a select group of individuals. The ROTEG is a newly developed coagulation analyzer which allows the continuous assessment of whole blood coagulation from the formation of the first fibrin fibers and activated platelets, to the formation of a three-dimensional whole blood clot until the eventual dissolution of the clot. This device will not be used as a diagnostic or procedure tool. No recommendations regarding interpretation of the results or implications for future treatment will be provided. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00178594
Study type Observational
Source The University of Texas Health Science Center, Houston
Contact Katherine Addy, RN, BSN, MPH
Phone 713-500-8352
Email Katherine.E.Addy@uth.tmc.edu
Status Recruiting
Phase
Start date October 2002
Completion date January 2024

See also
  Status Clinical Trial Phase
Recruiting NCT01339611 - Education Program for Patients Receiving Oral Anticoagulation N/A
Completed NCT03734588 - Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors Phase 1/Phase 2
Completed NCT03876301 - Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
Completed NCT04272554 - AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)